Colgate-Palmolive (CL) Q2 Earnings Report Preview: What To Look For

Consumer products company Colgate-Palmolive (NYSE:CL) will be reporting results this Friday before market hours. Here’s what to look for.

Colgate-Palmolive beat analysts’ revenue expectations by 0.6% last quarter, reporting revenues of $4.91 billion, down 3.1% year on year. It was a satisfactory quarter for the company, with a solid beat of analysts’ EBITDA estimates but a miss of analysts’ organic revenue estimates.

Is Colgate-Palmolive a buy or sell going into earnings? Read our full analysis here, it’s free.

This quarter, analysts are expecting Colgate-Palmolive’s revenue to be flat year on year at $5.03 billion, slowing from the 4.9% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.89 per share.

Heading into earnings, analysts covering the company have grown increasingly bearish with revenue estimates seeing 11 downward revisions over the last 30 days (we track 12 analysts). Colgate-Palmolive has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 1% on average.

Looking at Colgate-Palmolive’s peers in the household products segment, some have already reported their Q2 results, giving us a hint as to what we can expect. Procter & Gamble delivered year-on-year revenue growth of 1.7%, meeting analysts’ expectations, and WD-40 reported revenues up 1.2%, falling short of estimates by 2.3%. Procter & Gamble traded down 2.8% following the results while WD-40’s stock price was unchanged.

Read our full analysis of Procter & Gamble’s results here and WD-40’s results here.

Investors in the household products segment have had steady hands going into earnings, with share prices flat over the last month. Colgate-Palmolive is down 7.3% during the same time and is heading into earnings with an average analyst price target of $98.61 (compared to the current share price of $85.30).

When a company has more cash than it knows what to do with, buying back its own shares can make a lot of sense–as long as the price is right. Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares. Click here to claim your Special Free Report on a fallen angel growth story that is already recovering from a setback.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.